Company Filing History:
Years Active: 2003-2007
Title: Aimee Freeman: Innovator in Protein Modification
Introduction
Aimee Freeman is a notable inventor based in Newbury Park, CA (US). She has made significant contributions to the field of protein modification, particularly through her innovative work on erythropoietin stimulating proteins. With a total of 2 patents to her name, Freeman's research has the potential to impact various medical applications.
Latest Patents
Freeman's latest patents include groundbreaking work on chemically modified novel erythropoietin stimulating protein compositions and methods. This invention broadly relates to the field of protein modification, focusing on the attachment of water-soluble polymers to novel erythropoietin stimulating protein (NESP). Her research aims to enhance the efficacy and stability of these proteins, which are crucial in treating anemia and other related conditions.
Career Highlights
Aimee Freeman is currently associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. Her role at Amgen allows her to collaborate with other experts in the field and contribute to the development of cutting-edge medical solutions. Freeman's work exemplifies the intersection of scientific research and practical application in the biotechnology sector.
Collaborations
Some of her notable coworkers include Olaf B Kinstler and Colin V Gegg. Their collaborative efforts have further advanced the research and development of protein modification techniques, enhancing the potential for new therapeutic options.
Conclusion
Aimee Freeman's contributions to the field of protein modification through her patents and work at Amgen Inc. highlight her role as an influential inventor. Her innovative approaches continue to pave the way for advancements in medical treatments.